You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 4, April 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Epilepsy
 •Neurogenetics
 •Alert me on articles by topic

Disruption of Sodium Bicarbonate Transporter SLC4A10 in a Patient With Complex Partial Epilepsy and Mental Retardation

Christina A. Gurnett, MD, PhD; Rose Veile, BS; John Zempel, MD, PhD; Lynn Blackburn, PhD; Michael Lovett, PhD; Anne Bowcock, PhD

Arch Neurol. 2008;65(4):550-553.

Objective  To determine gene(s) disrupted in a patient with partial frontal lobe epilepsy and cognitive impairment with concomitant de novo balanced chromosomal translocation t(2;13)(q24;q31).

Design  Fluorescence in situ hybridization and array comparative genomic hybridization were used to map the locations of chromosomal translocation breakpoints.

Results  SLC4A10 (OMIM 605556), a sodium bicarbonate transporter gene with high expression in the cerebral cortex and hippocampus, was disrupted by the translocation breakpoint on chromosome 2q24. The breakpoint on chromosome 13q31 was in a 1-megabase (Mb)–gene desert. Genomewide array comparative genomic hybridization confirmed the absence of additional chromosomal abnormalities.

Conclusion  SLC4A10 is the third SLC4 base transporter family member to be implicated in human cognition and epilepsy.


Author Affiliations: Departments of Neurology (Drs Gurnett and Zempel), Pediatrics (Dr Gurnett), and Genetics (Ms Veile and Drs Lovett and Bowcock), Washington University School of Medicine, St Louis, Missouri; and Department of Neurology, Medical College of Wisconsin, Milwaukee (Dr Blackburn).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.